+ Filter



HIV-1 Protease

Anti-HIV-1 Protease Products
- Recombinant Anti-HIV-1 Protease Antibody (MOB-490)
-
- Derivation: Mouse
- Species Reactivity: HIV
- Type: IgG
- Application: ELISA, IP, FuncS
-
- Derivation: Human
- Species Reactivity: HIV
- Type: IgG
- Application: ELISA, WB, IP, FuncS
-
- Species Reactivity: HIV-1
- Type: Mouse IgG
- Application: WB, ELISA, FuncS
-
- Species Reactivity: HIV-1
- Type: Mouse IgG1, κ
- Application: WB, ELISA, FuncS
-
- Species Reactivity: HIV-1
- Type: Mouse scFv
- Application: WB, ELISA, FuncS
-
- Species Reactivity: HIV-1
- Type: Mouse scFv
- Application: WB, ELISA, FuncS
-
- Species Reactivity: HIV-1
- Type: Mouse Fab
- Application: WB, ELISA, FuncS
-
- Species Reactivity: HIV-1
- Type: Mouse Fab
- Application: WB, ELISA, FuncS
- Recombinant Human Anti-HIV-1 Protease Antibody Fab Fragment (MHH-490-F(E))
-
- Derivation: Human
- Species Reactivity: HIV
- Type: Fab
- Application: IF, ELISA, FuncS
- Recombinant Human Anti-HIV-1 Protease Antibody scFv Fragment (MHH-490-S(P))
-
- Derivation: Human
- Species Reactivity: HIV
- Type: scFv
- Application: FC, ELISA, FuncS
- Recombinant Anti-HIV-1 Protease Antibody Fab Fragment (MOB-490-F(E))
-
- Derivation: Mouse
- Species Reactivity: HIV
- Type: Fab
- Application: WB, ELISA, FuncS
- Recombinant Anti-HIV-1 Protease Antibody scFv Fragment (MOB-490-S(P))
-
- Derivation: Mouse
- Species Reactivity: HIV
- Type: scFv
- Application: Neut, WB, FuncS
View More Products
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
More Infomation
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
For Research Use Only. Not For Clinical Use.
Background
HIV-1 protease is a retroviral aspartyl protease (retropepsin) that is essential for the life-cycle of HIV, the retrovirus that causes AIDS. HIV protease cleaves newly synthesized polyproteins at the appropriate places to create the mature protein components of an infectious HIV virion. Without effective HIV protease, HIV virions remain uninfectious. Thus, mutation of HIV protease's active site or inhibition of its activity disrupts HIV's ability to replicate and infect additional cells, making HIV protease inhibition the subject of considerable pharmaceutical research.